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Objectives This study sought to compare the in-hospital prognostic values of the original and up-
dated GRACE (Global Registry of Acute Coronary Events) risk score (RS) and the AR-G (ACTION
[Acute Coronary Treatment and Intervention Outcomes Network] Registry and the GWTG [Get With
the Guidelines] Database) RS in acute coronary syndromes (ACS). To evaluate the utility of recalcu-
lating risk after percutaneous coronary intervention (PCI) with newer RS models (NCDR [National
Cardiovascular Data Registry] and EHS [EuroHeart Score] RS).
Background Deﬁned in 2003, GRACE is among the most popular systems of risk stratiﬁcation in
ACS. An updated version of GRACE has since appeared and new RS have been developed, aiming to
improve risk prediction.
Methods From 2004 to 2010, 4,497 consecutive patients admitted to a single center in Spain with an
ACS were included (32.1% ST-segment elevation myocardial infarction, 19.2% unstable angina). Discrimi-
nation (C-statistic) and calibration (Hosmer-Lemeshow [HL]) indexes were used to assess performance of
each RS. A comparative analysis of RS designed to predict post-PCI mortality NCDR and EHS RS versus the
GRACE and AR-G RS was performed in a subgroup of 1,113 consecutive patients included in the study.
Results There were 265 in-hospital deaths (5.9%). Original and updated GRACE RS and the AR-G RS
all demonstrated good discrimination for in-hospital death (C-statistics: 0.91, 0.90 and 0.90, respec-
tively) with optimal calibration (HL p: 0.42, 0.50, and 0.47, respectively) in all spectra of ACS, accord-
ing to different managements (PCI vs. conservative) and without signiﬁcant differences between the
3 different RS. In patients undergoing PCI, EHS and NCDR RS (C-statistic  0.80 and 0.84, respec-
ively) were not superior to GRACE RS (C-statistic  0.91), albeit in the subgroup of patients under-
going PCI who were categorized as high risk using the GRACE RS, both EHS and NCDR have contrib-
uted to decrease the false positive rate generated by using the GRACE RS.
Conclusions Despite having been developed over 8 years ago, the GRACE RS still maintains its ex-
cellent performance for predicting in-hospital risk of death among ACS patients. (J Am Coll Cardiol
Intv 2012;5:1117–25) © 2012 by the American College of Cardiology Foundation
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1118Risk stratification plays a pivotal role in optimizing man-
agement of acute coronary syndrome (ACS). It is the basis
on which decisions are made about level of care, need for
transfer to a tertiary care center, and specific pharmacolog-
ical and interventional treatments (1). Although clinicians
can stratify risk in their patients with ACS at a general level
using clinical parameters, electrocardiographic changes, and
biochemical cardiac markers, determination of risk for
specific adverse outcomes requires the integration of multi-
ple sources of information (2). Indeed, American College of
Cardiology/American Heart Association (ACC/AHA)
guidelines state that “estimation of the level of risk is a
multivariable problem that cannot be accurately quantified
with a simple table” (3). Among
several risk scores for predicting
in-hospital mortality, the fo-
cused update of ACC/AHA
ACS guidelines (4) and the cur-
rent European Society of Cardi-
ology Guidelines (5) recognize
the GRACE (Global Registry of
Acute Coronary Events) (6,7)
and the TIMI (Thrombolysis In
Myocardial Infarction) (8) risk
scores (RS) as the most accurate
scoring systems for in-hospital
death risk assessment (9,10).
Recently, Pieper et al. (11) up-
dated the in-hospital death
GRACE RS, with the inclusion
of nonlinear and interaction
terms, thus improving its predic-
tive value. A more contemporary
RS for in-hospital death, known
as AR-G (ACTION-GWTG)
RS, has also been derived from a
combined population consisting
of patients in the ACTION
(Acute Coronary Treatment and
Intervention Outcomes Net-
work) registry and the GWTG
(Get With the Guidelines) database (12). In addition, there
are 2 current models for predicting in-hospital risk of death
following percutaneous coronary intervention (PCI), not
only in the context of an ACS: the NCDR (National
Cardiovascular Data Registry) CathPCI RS (13) and the
EHS (EuroHeart Score) (14). Both models are designed on
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its own predictors. Notably, none of the recently developed
RS (i.e., updated GRACE, AR-G, NCDR, and EHS) has
been externally validated. Moreover, there are no data
available about whether NCDR and EHS RS provide any
incremental prognostic value over the GRACE RS in the
dynamic process of death risk prediction. Accordingly, we
compared performance of the original and updated
GRACE RS, and the AR-G RS, to predict in-hospital
mortality. Additionally, in a subgroup of patients undergo-
ing PCI, we assessed the ability of the NCDR and EHS RS
models to predict in-hospital risk of death and compared
their performance with that provided by GRACE and
AR-G RS.
Methods
Data sources and samples. This was a retrospective study in
hich demographic, clinical, and angiographic data, as well
s data on management and in-hospital complications, had
een prospectively collected and recorded in an electronic
atabase. Subjects were all patients with a diagnosis of ACS
dmitted consecutively to our hospital between January
004 and June 2010. ACS diagnosis was validated if the
atient had new onset symptoms consistent with cardiac
schemia and at least one of the following criteria: cardiac
iomarkers above the higher normal laboratory limit; ST-
egment deviation on electrocardiogram; in-hospital stress
esting showing ischemia; or known history of coronary
essel disease. Patients were classified as having acute
yocardial infarction with ST-segment elevation myocar-
ial infarction (STEMI) or non–ST-segment elevation
cute coronary syndrome (NSTE-ACS) (unstable angina
nd non–ST-segment elevation acute myocardial infarc-
ion). The initial cohort consisted of 4,645 patients. We
hen excluded the following patients: those in whom ACS
as precipitated in the context of surgery, sepsis, trauma, or
ocaine consumption (n  41); and those with missing data
or any variable making up an RS under assessment (n 
07). Thus, the final cohort was composed of 4,497 pa-
ients. We then divided this study population into 2 sets:
rst, all patients, which was used to compare the perfor-
ance of the original and updated GRACE RS (6,11) and
he AR-G RS (12); and second, patients admitted between
anuary 2007 and July 2010 who underwent PCI during the
ndex episode (n  1,113). This second set was used to
ompare the performance of RS developed specifically for
redicting in-hospital mortality in PCI patients—NCDR
13) and EuroHeart (14) PCI RS—with those for predict-
ng in-hospital mortality across the entire ACS popula-
ion—the original and updated GRACE RS, and the
R-G RS.
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1119Endpoint deﬁnitions. Primary endpoints were all-cause in-
hospital mortality, originally designated to be predicted by
all the scores explored in this study.
Risk scores calculation. RS were calculated for each patient
rom the sum of the individual scores assigned to each of
heir corresponding variables (Online Appendix), as was
reviously described (6,11,12); thus, the total sum of these
oints corresponded to the total RS as a continuous variable.
n addition, patients were categorized to different risk
roups according to cutoff points and intervals established
y each of the RS (see Online Appendix). Accordingly, 3
isk categories were established from the original and
pdated GRACE RS, whereas patients were assigned to 5
isk strata using the AR-G score.
We used the following standard clinical criteria to stratify
isk of death in ACS patients: presence of elevated cardiac
roponin I on admission (any elevation 0.1 ng/dl); ST-
egment deviation 2 mm in 2 contiguous leads; and/or
eart failure at presentation.
Calibration and discrimination. Indexes of calibration and
discrimination were used to assess performance of the
various RS studied. We used the Hosmer-Lemeshow (HL)
goodness-of-fit test to assess calibration (15), in which
higher p values indicate better calibration. Each RS was
entered, separately, into a logistic regression model to
generate the individual risk probability of death. The HL
statistic from the regression modeling was used as an
indicator of goodness-of-fit of each RS as a global predictor
variable. Discriminative power of each RS was assessed by
the C-statistic, equivalent to the area under the receiver-
operating characteristics curve (16). A model with a
C-statistic 0.75 was considered to have meaningful dis-
criminatory ability. Negative and positive predictive values
for each RS and risk stratification according to clinical
criteria were also computed for the high-risk group.
Statistical analysis. Discrete variables are expressed as fre-
uencies and percentages, and quantitative data are pre-
ented as the mean  SD. Chi-square test was used to
ompare discrete variables and the Student t test to compare
uantitative variables. The discriminatory abilities of the
riginal and updated GRACE RS, as well as the AR-G
core for in-hospital death were computed and compared
ccording to the nonparametric method described by De-
ong et al. (17). A p value 0.05 was considered statisti-
ally significant. All analyses were performed using SPSS
version 17.0, SPSS Inc., Chicago, Illinois) software and
edcalc (Mariakerke, Belgium).
esults
Baseline characteristics. Table 1 shows patient characteris-
ics, overall and in subgroups of survivors and nonsurvivors.
total of 338 patients (7.5%) were transferred from otherenters, and 268 (5.9%) patients died in hospital. Asxpected, patients who died were older and more likely to
ave a greater comorbidities burden, such as diabetes,
istory of heart failure, vascular disease, chronic obstructive
ulmonary disease, and prior malignancy, than were those
ho survived the index event. Similarly, they were more
ikely to be at Killip class II at admission, to present with
TEMI, to have more reduced left ventricular ejection
raction and more severe valvular heart disease. Nonsurvivor
atients were also more likely to have lower admission
emoglobin, lower glomerular filtrate rate, as well as and
ore extensive coronary artery disease involving both the
eft main and proximal left anterior descending coronary
rteries. Similarly, nonsurvivors had less frequently under-
one PCI procedures.
Predictive accuracy of RS. Both the original and updated
GRACE and AR-G RS showed excellent discrimination
and calibration together with marked risk gradients (Fig. 1),
regardless of whether the population was taken as a whole,
categorized in terms of type of ACS (STEMI vs. NSTE-
ACS), or divided into subgroups of patients undergoing
PCI or not (Table 2, Fig. 2). Neither the updated GRACE
RS nor the more contemporary AR-G RS outperformed the
original GRACE RS in any of the subgroups analyzed (all
p values 0.1 for comparison of C-statistic values of the 3
scores). Similarly, the discriminative capacity of the 3 scores
did not differ significantly in the following risk subgroups:
women; patients aged 75 years; and in those patients with
diabetes mellitus, chronic renal failure (defined as glomer-
ular filtration rate 60 ml/min/1.73 m2), and peripheral
rtery disease (Online Table 1).
Sensitivity and specificity, together with the positive and
egative predictive values of the GRACE and other RS, and
isk stratification based on clinical criteria, are shown in
able 3. The original GRACE RS had the highest negative
redictive value (false negative rate 0.6%, equal to clinical
riteria) with an optimal specificity (62.1% vs. 11.6% of
linical criteria). The updated GRACE RS did not improve
he predictive accuracy of the original version of GRACE.
owever, AR-G RS reduced the false positive rate when
ompared with the original GRACE and with clinical
riteria (72.7% vs. 86.3% vs. 93.4% for the AR-G, original
RACE RS and clinical criteria, respectively) but with a
ignificantly higher rate of false negatives (1.8%, a 3-fold
ncrease over the original GRACE RS).
Role of contemporary RS for predicting in-hospital mortality
following PCI. NCDR and EHS RS were validated in all
consecutive patients undergoing PCI from January 2007 to
July 2010. Of the 1,113 patients included, 48 died in
hospital (4.3%). Both EHS and NCDR models showed
excellent discrimination (C-statistic  0.855 [95% confi-
dence interval (CI): 0.833 to 0.875] and 0.894 [95% CI:
0.875 to 0.912] for the EHS and NCDR RS, respectively),
and good calibration (HL p values 0.71 and 0.33, respec-
tively). The C-statistic values for these models were lower
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1120than those obtained for GRACE, although the difference
was only significant with respect to the EHS RS (p 
0.045).
Categorizing patients in terms of the original GRACE
RS, in groups of low or moderate risk (mortality rate 1%
in our study population), the use of EHS or NCDR RS did
not provide any important prognostic information on risk
following PCI. However, in the group defined by GRACE
as high risk, both PCI score systems did provide important
Table 1. Baseline Characteristics of Study Patients
Total Population
Demographic data
Age, yrs 68.1 13.0
Female 28.7
Medical history
BMI, kg/m2 28.6 4.3
Diabetes 27.4
Hypertension 54.6
Dyslipidemia 44.5
Prior CAD 23.2
Prior CHF 4.0
Prior stroke 6.7
Peripheral vascular
disease
9.1
COPD 10.9
Prior malignancy 6.7
On-admission data
ACS
UA 19.2
NSTEMI 48.7
STEMI 32.1
Killip class II 18.4
Cardiac arrest 1.6
ST-segment deviation 51.9
Hemoglobin, g/dl 13.9 1.8
Serum creatinine, mg/dl 1.1 0.7
Procedural characteristics
LVEF 45%* 16.5
Multivessel disease 35.1
Coronary segment
Left main 3.7
pLAD 12.4
Revascularization
Non (medical therapy) 33.7
Thrombolytic 1.8
PCI 61.1
CABG 3.4
PCI nonsatisfactory 39.4
Values are mean SD or percentages. *Data of LVEF available in 3,89
ACS acute coronary syndrome; BMIbodymass index; CABG c
heart failure; COPD  chronic obstructive pulmonary disease; LVEF
myocardial infarction; PCI  percutaneous coronary intervention; p
elevation myocardial infarction; UA unstable angina.additional information. From the 1,113 patients who un-derwent PCI from January 2007 to July 2010, 423 were
classified in the high-risk GRACE group, with an in-
hospital mortality of 10.6%.
Figure 3 shows the rate of in-hospital death in the
high-risk GRACE group, according to NCDR and EHS
RS. In this selected sample of patients, both models (EHS
and NCDR RS) showed good discrimination (C-statistics 
0.801 and 0.842 for EHS and NCDR RS, respectively), and
calibration (HL p value  0.579 and 0.640, respectively).
Nonsurvivors Survivors p Value
77.1 10.4 67.5 12.9 0.001
35.1 28.3 0.017
27.4 4.0 28.7 4.3 0.093
41.0 26.5 0.001
54.9 54.6 0.942
34.3 45.1 0.001
26.9 23.0 0.144
13.1 3.5 0.001
12.7 6.3 0.001
13.8 8.8 0.006
16.4 10.6 0.003
10.4 6.5 0.011
1.9 20.3 0.001
45.5 52.6
48.9 30.8
75.0 14.8 0.001
9.3 1.1 0.001
85.4 49.8 0.001
12.9 2.1 14.0 1.7 0.001
1.7 1.6 1.1 0.6 0.001
63.0 14.3 0.001
38.8 34.9 0.194
11.6 3.2 0.001
21.6 11.8 0.001
45.9 32.9 0.001
2.6 1.8
45.9 62.1
5.6 3.2
59.2 38.5 0.001
ts.
artery bypass graft; CAD coronary artery disease; CHF congestive
ventricular ejection fraction; NSTEMI  non–ST-segment elevation
proximal left anterior descendent coronary; STEMI  ST-segment3 patien
oronary
 left
LAD Furthermore, both systems improved in-hospital mortality risk

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1121prediction by reducing the number of false positive rates. The
application of EHS and NCDR RS in this high-risk subgroup
of patients resulted in a substantial reduction of the false
positive rates (from 90% to 40% for EHS RS and from
90% to 57.5% for NCDR RS), due to lower sensitivity
25.0% for EHS and 64.6% for NCDR RS).
iscussion
We made several clinically important observations in this
study. First, the GRACE RS is a useful tool in risk
stratification in ACS, with a sensitivity similar to standard
clinical criteria but with a higher specificity. Second, after
Figure 1. In-Hospital Death Rates
Distribution of the in-hospital death rates in different risk groups according to
the 3 scoring systems analyzed. AR-G  ACTION (Acute Coronary Treatment
and Intervention Outcomes Network) Registry and the GTWG (Get With the
Guidelines) Database; GRACE  Global Registry of Acute Cardiac Events.discrimination and calibration analyses of the patient pop- Gulation as a whole, categorized by type of ACS, and
stratified according to whether a patient underwent PCI,
the more contemporary RS (AR-G and updated GRACE
RS) failed to improve the predictive ability of the original
in-hospital death of GRACE RS, which was developed over
8 years ago. Third, in patients undergoing PCI, neither
EHS nor NCDR RS were superior to GRACE RS, despite
the fact that the GRACE RS was developed in a cohort of
patients with a much lower rate of PCI (50% in STEMI
and 30% in NSTE-ACS). Indeed, the discriminatory
power of EHS RS was found to be significantly inferior to
GRACE RS. However, in the subgroup of patients at high
risk as defined by the GRACE scoring system, both EHS
and NCDR RS minimized the overestimated risk of death
(false positive rate) provided by the GRACE RS.
In our study, the predictive capacity of in-hospital death
after an ACS was excellent for both the original and
updated versions of GRACE RS and for the AR-G RS.
The original GRACE RS has already been validated in
numerous studies since its publication in 2003 (9,18–22).
By contrast, previous to our study, neither the updated
GRACE RS nor AR-G RS had been validated in an
independent dataset of ACS patients.
In this study, we found that the original GRACE RS had
a similar sensitivity to that obtained with clinical criteria,
increasing specificity 4-fold and reducing the false positive
rate by 6.8%. This might be due to variables, such as age,
heart rate, systolic blood pressure, and creatinine level
having been entered as continuous variables, resulting in
more accurate risk stratification, and thus reducing the
overestimation of risk of death based on clinical criteria. By
contrast, the updated GRACE score did not improve any of
these parameters in comparison with the original version.
The AR-G RS, however, showed a false-negative rate
3-fold higher than either GRACE RS or clinical criteria, an
unacceptable level given that the predicted event is in-
hospital mortality, although it did increase specificity and
reduce the rate of false positives obtained with GRACE.
These results could be explained by analyzing the models
used to derive the various RS. The updated GRACE RS
was derived from the same registry (an international multi-
center prospective registry) and using the same variables as
the original GRACE but over a longer period (1999 to
2006) (11) and with changes to the scoring system. The
main change has been to minimize the importance of Killip
class but maximize that of kidney function. The discrimi-
native capacity was similar in both versions (C-statistics 
.907 and 0.896 for the original and updated GRACE,
espectively). However, the fact that updated GRACE RS
inimizes the presence of heart failure at admission might
ustify, at least partially, that the percentage of patients in
on-high-risk groups who presented hospital death (false
egatives) was 2.6 higher in comparison with the original
RACE version.
ions as
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1122In contrast to GRACE, the AR-G RS is derived from a
multicenter registry limited to the United States, between
2007 and 2008, and of hospitals who participated volun-
tarily, excluding patients transferred from other centers (12).
The registry is, however, more contemporary than that of
GRACE, with almost twice the rate of PCI (45% of
patients having PCI, of which 80% are primary PCI). The
composition of the 2 systems is very similar, the differences
being the sole addition of peripheral artery disease and
assessing markers of myocardial damage as a continuous
variable. Thus, the discriminative power of each of the 2 RS
is expected to be very similar. In fact, a recent study showed
that the addition of ultrasensitive troponin measurement did
not provide important additional information over that in
GRACE RS (20). Moreover, several predictors specifically
included in the new RS, such as peripheral artery disease,
are at least indirectly accounted for by GRACE RS.
Both the GRACE and AR-G RS were designed for use
in the emergency department during initial medical exam-
ination; however, due to the dynamic nature of ACS
pathogenesis, the patient’s risk should be subsequently
Table 2. Observed and Predicted Rates (95% CI) for In-Hospital Mortality i
Risk Score by Groups
of Patients n Observed, % Exp
Origi
Overall 4,497 5.9 (5.2–6.6) 6.0
STEMI 1,443 9.8 (8.2–11.3) 9.8
NSTE-ACS 3,054 4.2 (3.4–4.9) 4.2
PCI
Yes 2,748 4.5 (3.7–5.2) 4.5
No 1,749 8.3 (7.0–9.6) 7.1
Upda
Overall 4,497 5.9 (5.2–6.6) 6.0
STEMI 1,443 9.8 (8.2–11.3) 9.8
NSTE-ACS 3,054 4.2 (3.4–4.9) 4.2
PCI
Yes 2,748 4.5 (3.7–5.2) 4.5
No 1,749 8.3 (7.0–9.6) 7.2
Overall 4,497 5.9 (5.2–6.6) 5.8
STEMI 1,443 9.8 (8.2–11.3) 9.4
NSTE-ACS 3,054 4.2 (3.4–4.9) 4.1
PCI
Yes 2,748 4.5 (3.7–5.2) 4.3
No 1,749 8.3 (7.0–9.6) 7.5
AR-G ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry and th
Cardiac Events; NSTE-ACS non–ST-segment elevation acute coronary syndrome; other abbreviatre-evaluated as further information is obtained. In patientsundergoing invasive management, therefore, it is desirable
that the risk of death is recalculated after catheterization
and/or PCI. The NCDR and EHS RS were designed
explicitly to determine the probability of in-hospital death
after PCI. The NCDR score (13) was derived from the
National Cardiovascular Data Registry, with data from
181,775 procedures performed from 2004 to 2006 in centers
in the United States, and the EHS RS (14) was based on the
EuroHeart Survey of PCI and contained information on
46,064 consecutive patients who underwent PCI due to
various indications in European centers from 2005 to 2008.
To date, however, no PCI-related RS has been externally
validated, nor its predictive ability compared with that of the
GRACE RS.
In our study, both the EHS and NCDR RS performed
very well for in-hospital mortality in patients with ACS
undergoing PCI. When compared with the GRACE RS,
the EHS was significantly lower, whereas the NCDR
showed no significant difference. This could be explained by
the composition of each scoring system. Thus, the EHS RS
does not include several widely recognized variables, such as
Entire Cohorts and Stratified by Type of ACS and Performing PCI
Calibration
, %
H-L
Discrimination
C-Statistic (95% CI)Chi-Square p Value
ACE
6) 8.123 0.422 0.907 (0.889–0.924)
.3) 9.370 0.312 0.904 (0.879–0.929)
9) 7.968 0.437 0.899 (0.874–0.925)
2) 10.243 0.248 0.915 (0.889–0.942)
3) 9.676 0.289 0.897 (0.873–0.920)
ACE
6) 7.328 0.502 0.896 (0.877–0.915)
.3) 5.060 0.751 0.906 (0.881–0.931)
9) 6.567 0.584 0.883 (0.855–0.910)
2) 2.791 0.947 0.914 (0.887–0.941)
4) 8.903 0.351 0.880 (0.854–0.906)
5) 7.587 0.475 0.901 (0.883–0.919)
.9) 2.967 0.936 0.894 (0.866–0.921)
8) 3.322 0.854 0.901 (0.876–0.927)
1) 7.171 0.518 0.916 (0.890–0.941)
7) 8.223 0.412 0.885 (0.860–0.911)
(Get With the Guidelines) Database; CI  confidence interval; GRACE Global Registry of Acute
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1123changes, or increased markers of myocardial necrosis. The
emphasis of EHS is on angiographic parameters, such as
multivessel disease, involvement of bifurcations or the cor-
onary segments as left main or proximal left anterior
descendent coronary artery, type-C lesions, or initial TIMI
flow grade. The NCDR RS, by contrast, includes renal
failure but does not recognize variables, such as blood
pressure, heart rate, presence of ST-segment changes, or
markers of myocardial necrosis; additionally, it assesses
mortality at 30 days rather than in-hospital death.
It is important to remember that both EHS and NCDR
RS were designed to assess risk after PCI not only in ACS
Figure 2. Risk Score Calibration
Calibration of risk scores by deciles of predicted risk in the overall population
cardial infarction and non–ST-segment elevation acute coronary syndrome). Abbut also in other scenarios (i.e., stable angina), whereasGRACE and AR-G RS were designed to evaluate initial
risk in the ACS scenario to optimize therapeutic strategy.
Our observation that the data obtained during catheteriza-
tion and used in these 2 RS (NCDR and EHS) do not
improve the initial prognostic assessment achieved with the
GRACE or the AR-G RS and should therefore be inter-
preted with caution, taking into account the different
patient settings. We have found a possible additive utility in
patients defined as high risk according to the original
GRACE RS (and who are therefore candidates for invasive
management). In these patients, NCDR and EHS RS
appear to show better discrimination of in-hospital risk of
different acute coronary syndrome subgroups (ST-segment elevation myo-
ations as in Figure 1.and indeath due to their reduction of the rate of false positives and
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1124optimization of the use of hospital resources, although they
do so at the expense of lowering sensitivity.
Clinical implications. With advances in ACS management,
a major objective has been the reduction of in-hospital
mortality (23,24). In this context, the use of RS has proven
to be very helpful to clinicians. It is especially important to
optimize the use of hospital resources because aggressive
strategies are not always tailored to higher-risk patients.
Thus, there has been a proliferation of risk stratification
systems. Studies such as ours provide a comparative assess-
ment of the usefulness and reliability of RS for predicting
in-hospital mortality. At present, no RS has proven superior
to the GRACE model in the risk prediction of in-hospital
death. European guidelines for ACS management (5) em-
phasize the importance of early risk stratification in ACS
using the GRACE RS (Class I, Level of Evidence: B).
However, neither the ACC/AHA guidelines nor their
recent focused update (4) explicitly recommend the employ-
ment of GRACE, even though its high predictive value is
recognized. We think that the application of risk stratification
systems, and specifically the GRACE RS, could be useful for
the proper management of ACS patients and the optimization
of their therapeutic care. We recommend, therefore, that
physicians should familiarize themselves with their use.
Study limitations. One limitation of this study is that inherent
o retrospective studies. A further limitation of the study is its
ingle institution nature. Only patients admitted to our insti-
ution, which is equipped to perform coronary angiography
nd PCI, were included; the applicability of the present results
hould therefore be viewed with caution in other centers with
ifferent therapeutic management patterns. However, findings
rom our registry offer the advantage of providing more
onsistent results compared with multicenter registries because
f the large variability in each center’s institutional protocols,
ence, risk stratification may not translate to a particular
enter’s experience. Another limitation of this study is the lack
f sample size calculation to discriminate between RS; there-
ore, the study could be underpowered to detect possible
Table 3. Sensitivity, Specificity, and Negative and Positive Predictive
Values for the Scores and Risk Stratification According to Clinical
Criteria
Risk Scores Sensitivity Specificity
Negative
Predictive
Value
Positive
Predictive
Value
Clinical criteria* 98.5 15.9 99.4 6.9
Original GRACE RS 94.4 62.1 99.4 13.7
Update GRACE RS 84.7 59.3 98.4 11.7
AR-G RS 74.0 87.8 98.2 27.3
*High-risk clinical criteria: presence of elevated cardiac troponin I on admission (any elevation
0.1 ng/dl), ST-segment deviation 2 mm in 2 contiguous leads, and/or heart failure at
presentation.
RS risk score; other abbreviations as in Table 2.ifferences between the RS’s discriminative capacity, particu-arly for predicting death in the subgroup of PCI patients
here only 48 events (i.e., in-hospital death) were observed.
inally, RS could not be calculated in 107 patients of our
ohort, ostensibly because of an absence of on-admission heart
ate. Nevertheless, the prevalence of missing data in our study
as modest when compared with other data registries.
onclusions
Despite its having been developed over eight years ago, the
GRACE RS still maintains its excellent performance in
predicting the in-hospital risk of death among ACS pa-
tients. Neither the updated version of GRACE RS nor new
scoring systems, such as the AR-G RS, exceed the predic-
tive ability of GRACE. In our study, the risk assessment of
in-hospital death after PCI using the more contemporary
PCI-based RS (i.e., EHS and NCDR scores) did not
improve the sensitivity of the GRACE score although
offered the advantage of reducing the false positive rate
generated by using the GRACE scoring system.
Figure 3. Mortality in High-Risk GRACE Subgroup
In-hospital risk of death of the high-risk GRACE (Global Registry of Acute
Cardiac Events) subgroup according to the EHS (EuroHeart Score) and
NCDR (National Cardiovascular Data Registry) scoring systems.
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